Tennessee Senate Bill SB1930

Tennessee 2023-2024 Regular Session

• Introduced: 1/24/24
• Engrossed: 4/9/24
• Enrolled: 4/19/24
• Passed: 5/1/24
• Chaptered: 5/9/24

Caption

AN ACT to amend Tennessee Code Annotated, Title 68, Chapter 5, relative to genetic testing.

Impact

If passed, SB1930 would significantly influence state health regulations by necessitating reviews and data collection on genetic testing related to renal diseases. The requirement for the department to analyze and devise methods for increased genetic awareness and testing programs would likely enhance preventative healthcare measures for individuals at risk. This could, in turn, lead to early detection and treatment interventions that significantly improve health outcomes for those affected by APOL1 variants.

Summary

Senate Bill 1930 focuses on addressing public health concerns related to genetic factors influencing health conditions, particularly the apolipoprotein L 1 (APOL1) gene, which is associated with a heightened risk of end-stage renal disease. The bill mandates the Tennessee Department of Health to conduct a comprehensive review and produce a report detailing recommendations for increasing awareness about the APOL1 gene, including potential strategies for genetic screening and testing. This initiative signifies a proactive approach to managing genetic predispositions that affect public health outcomes.

Sentiment

The sentiment surrounding SB1930 appears to be largely positive, particularly among health advocates and professionals who recognize the importance of addressing genetic factors in public health. Supporters of the bill see the measure as a critical step in combating diseases that disproportionately affect certain populations. There may be concerns among some groups about the implications of genetic testing and privacy issues; however, these discussions seem to be secondary to the overarching goal of improving health outcomes through genetic insight and intervention.

Contention

Notable points of contention may arise from how genetic information is utilized and the potential consequences for individuals who undergo testing. Issues surrounding healthcare access, resource allocation for testing and screening programs, and data privacy are expected focal points of debate as stakeholders weigh the benefits of the bill against the possible ethical implications of greater genetic testing initiatives. Overall, SB1930 represents a push toward integrating genetic understanding into public health strategies, albeit not without concerns about its broader societal impacts.